These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Complications resulting from the insertion of contraceptive pessaries]. Feige A Med Klin; 1981 Feb; 76(4):93-4. PubMed ID: 7219337 [No Abstract] [Full Text] [Related]
23. [Postplacental application of 5 different types of intrauterine devices]. Reynoso L; Arevalo N; Lara R; Aznar R Ginecol Obstet Mex; 1982 May; 50(301):107-10. PubMed ID: 7182224 [TBL] [Abstract][Full Text] [Related]
24. Medicated intrauterine devices: development considerations and clinical uses. Chien YW J Parenter Drug Assoc; 1980; 34(4):295-323. PubMed ID: 6902777 [TBL] [Abstract][Full Text] [Related]
26. [Ultrastructural changes in the endometrium of women using progesterone-releasing intrauterine devices for more than 5 years]. González Angulo A; Aznar Ramos R Arch Invest Med (Mex); 1988; 19(3):319-28. PubMed ID: 3242440 [No Abstract] [Full Text] [Related]
27. Rosacea in association with the progesterone-releasing intrauterine contraceptive device. Choudry K; Humphreys F; Menage J Clin Exp Dermatol; 2001 Jan; 26(1):102. PubMed ID: 11260192 [No Abstract] [Full Text] [Related]
28. The impact of intrauterine devices on subsequent fertility. Skjeldestad FE Curr Opin Obstet Gynecol; 2008 Jun; 20(3):275-80. PubMed ID: 18460943 [TBL] [Abstract][Full Text] [Related]
29. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)]. Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443 [TBL] [Abstract][Full Text] [Related]
30. Studies on norgestrel-releasing intrauterine devices in Erythrocebus patas monkeys. Doyle LL; Harrison RM Int J Fertil; 1981; 26(2):112-5. PubMed ID: 6114061 [No Abstract] [Full Text] [Related]
31. [Progestasert and copper-T. A prospective, randomized clinical study of 2 coil types]. Larsen S; Hansen MK; Jacobsen JC; Ladehoff P; Sørensen T; Westergaard JG Ugeskr Laeger; 1980 Dec; 143(1):13-4. PubMed ID: 7018042 [TBL] [Abstract][Full Text] [Related]
32. [Migration of an intrauterine device after salpingectomy. Translocation of an in situ intrauterine device to the abdominal cavity after tubal pregnancy and salpingectomy]. Trolle C; Sommer W Tidsskr Nor Laegeforen; 1987 Apr; 107(12):1029, 1036. PubMed ID: 3603456 [No Abstract] [Full Text] [Related]
33. [Clinical study of the copper intrauterine T contraceptive device]. Rustrián Azamar A Ginecol Obstet Mex; 1976 Sep; 40(239):207-9. PubMed ID: 976763 [TBL] [Abstract][Full Text] [Related]
35. Clinical experience with Progestasert beyond one year of use. Wan LS Contracept Deliv Syst; 1981 Jul; 2(3):243-8. PubMed ID: 12278911 [TBL] [Abstract][Full Text] [Related]
37. [Clinical and morphological studies in patients with a progesterone-releasing intrauterine contraceptive device (Progestasert-System) (author's transl)]. Sievers S; Dallenbach-Hellweg G Geburtshilfe Frauenheilkd; 1976 Apr; 36(4):334-40. PubMed ID: 1269894 [TBL] [Abstract][Full Text] [Related]
38. [Long-term results of treatment with Progestasert for the control of fertility]. Leone U; Stellatelli M; Di Girolamo V Minerva Ginecol; 1978; 30(7-8):667-9. PubMed ID: 683616 [No Abstract] [Full Text] [Related]
39. [Controlling of intrauterine devices should increase in Sweden]. Milsom I; Andersson K; Odlind V Lakartidningen; 1997 May; 94(20):1908-10. PubMed ID: 9190482 [No Abstract] [Full Text] [Related]